期刊文献+

老年门诊人群骨密度和糖脂代谢指标的相关性研究 被引量:1

Relationship between bone mineral density and glucolipid metabolism index of elderly outpatient
下载PDF
导出
摘要 目的 观察老年门诊人群骨密度和糖脂代谢指标的相关性.方法 老年门诊就诊的60岁及以上患者196例,采用骨密度超声分析仪(QUS)对其进行骨密度的测定,根据检测结果分为骨量正常组、骨量减少组和骨质疏松组.并对患者进行问卷调查,包括年龄、身高、体重、疾病史以及空腹血糖、糖化血红蛋白、血脂、血钙、血磷、骨转换指标测定,分析老年骨质疏松的影响因素及和糖脂代谢指标的相关性.结果 空腹血糖、糖化血红蛋白、Ⅰ型胶原羧基端肽β特殊序列、25-羟维生素D3与骨密度T值呈相关关系(P分别为0.000,0.004,0.015,0.018;相关系数分别为-0.320,-0.207,-0.173,0.169),进一步的多因素分析显示,空腹血糖与老年骨量下降呈相关性(P=0.011,相对危险度1.709,95%可信区间1.133 ~ 2.579).伴有糖尿病的骨质疏松患者Ⅰ型胶原羧基端肽β特殊序列高于非糖尿病组(P =0.029),而骨痛症状却较少(P=0.013).结论 空腹血糖是老年门诊人群骨密度下降的危险因素.高血糖患者较易患骨质疏松,其骨代谢改变特点是:骨形成下降、骨吸收增加.在治疗2型糖尿病的同时,对老年人早期进行骨密度测定有重大意义. Objective To investigate the relationship between bone mineral density and glucolipid metabolism index of elderly outpatient. Methods Bone mineral density was investigated by Quantitative ultrasound (QUS) in 196 patients aged above 60 years who received physical examination in outpatient department. All subjects answered the questionnaire, which contained the information on age, height, weight, previous disease history. Additionally, fasting plasma glucose, glycosylated hemoglobin, blood lipids, blood calcium, blood phosphorus and bone turnover markers were also measured. The relationship between these factors and glucolipid metabolism were investigated. Results Fasting plasma glucose, glycosylated hemoglobin, β-C-terminal cross-linked telopeptides of type I collagen, 25- hydroxy vitamin D3 were correlated with bone mineral density (P=0.000, 0.004, 0.015, 0.018 respectively ). Fasting plasma glucose were correlated with bone mineral density (P= 0.011 ). ~ crosslaps carboxy terminal telopeptides of collagen type 1 in diabetic osteoporosis group was significantly higher than the non-diabetic group, but less pain symptoms. Conclusion Fasting plasma glucose, is a risk factor for decreased bone mineral density of elderly outpatient. The bone metabolism change characteristic is: decreased bone formation, increase bone resorption. It is strongly recommended that patients with type 2 diabetes should timely undergo bone mineral density measurement.
出处 《老年医学与保健》 CAS 2014年第3期189-192,共4页 Geriatrics & Health Care
关键词 骨密度 老年人 骨质疏松 糖脂代谢 2型糖尿病 Bone mineral density Elderly Osteoporosis Glucolipid metabolism Type 2 diabetes
  • 相关文献

参考文献11

  • 1陆再英,钟南山.内科学[M].第7版.北京:人民卫生出版社.2008:251.
  • 2Kiel DP, Kauppila LI, Cupples LA, et al. Bone loss and the progression of abdominal aortic calcification over a 25 year per- iod: the Framingham Heart Study [J]. Calcif Tissue Int, 2001, 68 (5): 271-276.
  • 3林兵,谢海宝,赵晶晶,文晓林,吕远栋,徐伟红,陶萍华.2型糖尿病患者双能X线骨密度测定[J].中国骨质疏松杂志,2005,11(2):218-220. 被引量:16
  • 4Parhami F. Possible role of oxidized lipids in osteoporosis: could hyperlipidemia be a risk factor [J]. Prostaglandins Leukot Essent Fatty Acid, 2003, 68 (6): 373-378.
  • 5Bridges MJ, Moochhala SH, Barbour J, et al. Influence of diabetes on peripheral bone mineral density in men: a controlled study [J]. ActaDiabetol, 2005, 42 (2): 82-86.
  • 6雷晨,周晓玲.2型糖尿病合并骨质疏松症患者的相关危险因素分析[J].中国临床康复,2004,8(21):4310-4311. 被引量:22
  • 7GopalakrishnanV, VigneshRC, ArunakaranJ, et al. Effects of glucose and its modulation by insulin and estradiol on BMSC differentiation into osteoblastic lineages [J]. Biochem Cell Biol, 2006, 84 (1): 93-101.
  • 8孙琳.糖尿病与骨质疏松研究进展[J].医学综述,2003,9(1):51-52. 被引量:25
  • 9Vestergaard P. Bone metabolism in type 2 diabetes and role of thiazolidmediones [J]. Curr Opm Endocrmol Diabetes Obes, 2009, 16 (2): 125-131.
  • 10Iwamoto J, Takeda T, Sato Y, et al. Comparison of the effect of alendronate on lumbar bone mineral density and bone turnover in men and postmenopausal women with osteoporosis [J]. ClinRheumatol, 2007, 26 (2): 161-167.

二级参考文献34

  • 1白洁 洪庆 陈凌.辛伐他汀对糖尿病性骨质疏松患者骨密度和骨转换的影响.中国临床康复,2003,7(5):870-1.
  • 2史轶蘩.协和内分泌和代谢学[M].北京:科学出版社,2000,1.1120.
  • 3KeminikSA,Hermus AR,Swinkels LM,et al.Osteopeia in insulin-dependent diabetes mellitus:prevalence and aspects of pathophysiology.J Endocrinol Invest 2000;23 (5) :295-303
  • 4Isaia GC,Ardisone P,Di Stefano M,et al.Bone metabolism in type Ⅱ diabetes mellitus.Acta Diabetol 1999;36(1-2) :35-8
  • 5Campos Pastor MM,Lopez-Ibarra PJ,Escobar-Jimmenez F,et al.Intensive insulin therapy and bone mineral density in type Ⅰ diabetes mellitus:a prospecctive study.Osteoporos Int 2000;11:455-9
  • 6Sahin G, Bagis S, Cimen OB, et al. Lumbar and femoral bone mineral density in type in 2 Turkish diabetic patients. Acta Medica (Hradec Kralove), 2001, 44 (4) : 141-143.
  • 7Hanley DA, Brown JP, Tenenhouse A, et al, Associations among disease conditions, bone mineral density, and prevalent vertebral deformities in men and women 50 years of age and older s cross-sectional results from the Canadian Multicentre Osteoprosis Study. J Bone Miner Res, 2003, 18:784-790.
  • 8Akin O, Gol K, Akturk M, et al. Evaluation of bone turnover in postmenopausal patients with type 2 diabetes mellitus using biochemical markers and bone mineral density measurements. Gynecol Endocrinol, 2003, 17 (1) : 19-29.
  • 9Schwartz AV, Sellmeyer DE, Ensrud KE, et al. Older women with diabetes have an increased risk of fracture: A prospective study. J Clin Endocrinol Metab, 2001, 86 : 32-38.
  • 10Nicodemus KK, Folsom AR. Type 1 type and 2 diabetes and incident hip fracture in postmenopausal women. Diabetes Care,2001, 24: 1192-1197.

共引文献1868

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部